drugset / Trial / NCT04374474

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

NCT04374474

RandomizedParallel-groupOpen-labelTreatment

Summary

The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care) and act as a control group. The second group will receive an essential oil retraining kit, whereas the third group will receive the same olfactory training kit and a prescription to use budesonide with the nasal irrigations. Olfactory scores will be tested at the enrollment, 3 months and at 6 months.

Timeline

Start
2021-01-10
Primary completion
2021-12-10
Completion
2022-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 0.5 mg Other